TITLE

Neisseria gonorrhoeae with Reduced Susceptibility to Azithromycin -- San Diego County, California, 2009

AUTHOR(S)
Katz, Kenneth A.; Pierce, Elaine F.; Aiem, Heidi; Henderson, Philip; Pandori, Mark; Wu, Abel; Buono, Sean; Barry, Pennan M.; Samuel, Michael; Kong, Carol; Weinstock, Hillard S.; Yee, Eileen L.; Kirkcaldy, Robert D.; Khaokham, Christina B.; Dixon, Paula; Bolan, Gail
PUB. DATE
May 2011
SOURCE
MMWR: Morbidity & Mortality Weekly Report;5/13/2011, Vol. 60 Issue 18, p579
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a report which summarizes the findings associated with reduced susceptibility to azithromycin in San Diego County, California in 2009. Clinicians treating cephalosporin-allergic patients with a 2 gram dose of azithromycin for uncomplicated gonorrhea are advised to obtain tests of cure after treatment and to recommend sexual abstinence. Continued surveillance for antibiotic resistance and effective control efforts are said to be important factors for the prevention of gonorrhea.
ACCESSION #
60882674

 

Related Articles

  • Table of Contents.  // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 11, pNP 

    The table of contents for the June 2013 issue of "Clinical Infectious Diseases" is presented.

  • CDC update on gonorrhea: Expand treatment to limit resistance. Campos-Outcalt, Doug // Journal of Family Practice;Dec2011, Vol. 60 Issue 12, p736 

    The article presents Centers for Disease Control and Prevention (CDC) updates on the treatment of gonorrhea in the U.S. in 2011. The CDC views as inevitable the ultimate development of resistance to cephalosporins, the preferred agents for gonorrhea, provided the speed where gonococci developed...

  • Gonococcal Infections, CDC's Updated Treatment. Elliott, William T. // Travel Medicine Advisor;Jun2007, Vol. 17 Issue 6, Special section p1 

    The article reports on the updated treatment recommendations for gonococcal infections and associated conditions issued by the U.S. Centers for Disease Control and Prevention. Current recommended regimens for gonococcal infections are 125 milligram (mg) ceftriaxone or 400 mg cefixime....

  • A Retrospective Comparative Study of 2-Drug Oral and Intramuscular Cephalosporin Treatment Regimens for Pharyngeal Gonorrhea. Barbee, Lindley A.; Kerani, Roxanne P.; Dombrowski, Julia C.; Soge, Olusegun O.; Golden, Matthew R. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 11, p1539 

    In this retrospective study, combination therapy with an oral cephalosporin and azithromycin was comparable to intramuscular ceftriaxone alone or with azithromycin for the treatment of pharyngeal gonorrhea. Combination therapy with doxycycline was associated with a higher risk of recurrent...

  • Azithromycin in gonorrhoea. Waugh, M. A. // International Journal of STD & AIDS;Jan1996 Supplement 1, Vol. 7, p2 

    The clinical applications of azithromycin in gonorrhoea, often complicated by simultaneously acquired infection with Chlamydia trachomatis , are reviewed in this paper. Clinical trials from major centres in Europe are compared with a large, more recent US study. At the present time, azithromycin...

  • Last resort.  // Down to Earth;7/16/2013, Vol. 22 Issue 5, p43 

    The article reports on the drop in antibiotic resistance cases in gonorrhea patients in Great Britain treated with high dose of azithromycin and ceftriaxone which may delay the rise of the completely untreatable sexually transmitted bacterial infection.

  • Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae--Hawaii and California, 2001.  // MMWR: Morbidity & Mortality Weekly Report;11/22/2002, Vol. 51 Issue 46, p1041 

    Summarizes investigations of increases in fluoroquinolone-resistant neisseria gonorrhoeae in Hawaii and California in 2001. Information on gonorrhea; Details on the use of cephalosporins for the treatment of gonorrhea; Background on fluoroquinolone therapy.

  • The Efficacy and Safety of Gentamicin Plus Azithromycin and Gemifloxacin Plus Azithromycin as Treatment of Uncomplicated Gonorrhea. Kirkcaldy, Robert D.; Weinstock, Hillard S.; Moore, Page C.; Philip, Susan S.; Wiesenfeld, Harold C.; Papp, John R.; Kerndt, Peter R.; Johnson, Shacondra; Ghanem, Khalil G.; Hook, Edward W. // Clinical Infectious Diseases;Oct2014, Vol. 59 Issue 8, p1083 

    We evaluated 2 combinations of existing antimicrobials for treatment of gonorrhea: gentamicin/azithromycin and gemifloxacin/azithromycin. Both regimens were efficacious, but many participants experienced gastrointestinal adverse events. These combinations may be useful options for patients who...

  • Gonorrhoea treatment position statement. Fifer, Helen; Hughes, Gwenda; Radcliffe, Keith // Sexually Transmitted Infections;Aug2015, Vol. 91 Issue 5, p307 

    The article focuses on the British Association of Sexual Health and HIV (BASHH) gonorrhea treatment guidelines, which was changed to ceftriaxone in combination with azithromycin as first-line therapy in 2011. The Gonococcal Resistance to Antimicrobials Surveillance Programme revealed that the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics